{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:27:34Z","timestamp":1793219254184,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T00:00:00Z","timestamp":1422835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.gastro.2015.01.037","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T12:51:50Z","timestamp":1422622310000},"page":"740-750.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis"],"prefix":"10.1053","volume":"148","author":[{"given":"William J.","family":"Sandborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bosworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salam","family":"Zakko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn L.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Clemmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Rolleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch","family":"Bortey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2015.01.037_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2015.01.037_bib2","first-page":"4","article-title":"Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes","volume":"5","author":"Hanauer","year":"2009","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1053\/j.gastro.2015.01.037_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/BF01295733","article-title":"Clinical patterns, natural history, and progression of ulcerative colitis. a long-term follow-up of 1116 patients","volume":"38","author":"Farmer","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2015.01.037_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2006.01.047","article-title":"American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.01.037_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1572-0241.2008.01836.x","article-title":"Immunosuppressant medications and mortality in inflammatory bowel disease","volume":"103","author":"Lewis","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.01.037_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.01.037_bib7","first-page":"CD004115","article-title":"Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"1","author":"Marshall","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2015.01.037_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/156720112801323062","article-title":"Foam preparations for the treatment of ulcerative colitis","volume":"9","author":"Loew","year":"2012","journal-title":"Curr Drug Deliv"},{"key":"10.1053\/j.gastro.2015.01.037_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1365-2036.1997.00193.x","article-title":"Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy","volume":"11","author":"Brown","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.01.037_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"key":"10.1053\/j.gastro.2015.01.037_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/bmj.2.5104.1072","article-title":"Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial","volume":"2","author":"Truelove","year":"1958","journal-title":"Br Med J"},{"key":"10.1053\/j.gastro.2015.01.037_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.crohns.2007.11.002","article-title":"European evidence-based Consensus on the management of ulcerative colitis: current management","volume":"2","author":"Travis","year":"2008","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2015.01.037_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1155\/1990\/708916","article-title":"Overview of newer glucocorticosteroid preparations for inflammatory bowel disease","volume":"4","author":"Brattsand","year":"1990","journal-title":"Can J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.01.037_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00042737-200212000-00012","article-title":"Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules","volume":"14","author":"Edsb\u00e4cker","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.01.037_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2003.01426.x","article-title":"A\u00a0pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules","volume":"17","author":"Edsb\u00e4cker","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.01.037_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0016-5085(98)70131-3","article-title":"Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study","volume":"115","author":"Hanauer","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.01.037_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2036.2010.04354.x","article-title":"Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis","volume":"32","author":"Hartmann","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.01.037_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.dld.2007.01.012","article-title":"Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study","volume":"39","author":"Biancone","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2015.01.037_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2036.2005.02571.x","article-title":"Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis","volume":"22","author":"Brunner","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.01.037_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10350-004-6687-x","article-title":"Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis","volume":"46","author":"Bar-Meir","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2015.01.037_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2036.2006.02743.x","article-title":"Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis","volume":"23","author":"Gross","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.01.037_bib22","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2015.01.037_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0025-6196(12)65511-6","article-title":"Statistical considerations for performing multiple tests in a single experiment. 5. Comparing two therapies with respect to several endpoints","volume":"63","author":"O'Brien","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2015.01.037_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/gut.3.3.201","article-title":"Observations on idiopathic proctitis","volume":"3","author":"Lennard-Jones","year":"1962","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.01.037_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0016-5085(87)90554-3","article-title":"Studies on the mechanism of bowel disturbance in ulcerative colitis","volume":"93","author":"Rao","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.01.037_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2125.2005.02517.x","article-title":"Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation","volume":"61","author":"Brunner","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2015.01.037_bib27","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2012.08.003","article-title":"Once-daily budesonide MMX\u00ae extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study","volume":"143","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.01.037_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/gutjnl-2012-304258","article-title":"Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study","volume":"63","author":"Travis","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.01.037_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0016-5085(98)70131-3","article-title":"Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group","volume":"115","author":"Hanauer","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.01.037_bib30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1572-0241.2002.05786.x","article-title":"Assessment of hypothalamic-pituitary-adrenal axis function after corticosteroid therapy in inflammatory bowel disease","volume":"97","author":"Desram\u00e9","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.01.037_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.40.6.775","article-title":"Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis","volume":"40","author":"Marshall","year":"1997","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.01.037_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.2.5348.24","article-title":"Adrenal cortical and pituitary function after intrarectal steroid therapy","volume":"2","author":"Matts","year":"1963","journal-title":"Br Med J"},{"key":"10.1053\/j.gastro.2015.01.037_bib33","first-page":"1345","article-title":"Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis","volume":"51","author":"Hammond","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.gastro.2015.01.037_bib34","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1111\/j.1572-0241.2008.02152.x","article-title":"Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis","volume":"103","author":"Cortot","year":"2008","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508515001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508515001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:09:27Z","timestamp":1758035367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508515001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0016508515001547"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2015.01.037","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2015.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}